(S)-Thalidomide; (-)-Thalidomide; 841-67-8; (S)-(-)-thalidomide; l-Thalidomide; S-(-)-Thalidomide; S-Thalidomide; Thalidomide, (-)-; Thalidomide, L-; (S)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; TG87FSR590; CHEBI:61918; (?)-Thalidomide; 2-[(3S)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione; 2-[(3S)-2,6-dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione; NSC 91730; SMR000857221; Thalidomide, (S)-; ENMD 0995; UNII-TG87FSR590; NSC-91730; CAS-50-35-1; EF2; Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (-)-; Phthalimide, N-(2,6-dioxo-3-piperidyl)-, L-(-)-; Tocris-0652; 4ci1; Lopac-T-144; 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)-; MLS001333073; MLS001333074; rac-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione; SCHEMBL455269; CHEMBL426123; 2-[(3S)-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione; DTXSID1046972; BDBM65457; ENMD-0995; HMS2230K15; (-)-Thalidomide, >98%, solid; ZINC1530947; HY-14658A; NCGC00015989-01; NCGC00015989-02; NCGC00016220-01; NCGC00024708-01; CS-0021928; EN300-7507076; A828082; S(-)-3-(3-AMINO-PHTHALIMIDO)-GLUTARAMIDE; Thalidomide; N-(2,6-dioxo-3-piperidyl)phalimide; Q27131493; 2-[(3S)-2,6-dioxo-3-piperidinyl]isoindole-1,3-dione; 2-[(3S)-2,6-bis(oxidanylidene)piperidin-3-yl]isoindole-1,3-dione